Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Bridgett Harr, CNP

Advertisement

Articles by Bridgett Harr, CNP

Bridgett Harr Discusses Survivorship for Patients With Head and Neck Cancer

ByBridgett Harr, CNP
October 18th 2016

Bridgett Harr of the Cleveland Clinic Cancer Center explains what survivorship might look like for patients with head and neck cancer.

Advertisement

Latest Updated Articles

  • Bridgett Harr Discusses Survivorship for Patients With Head and Neck Cancer
    Bridgett Harr Discusses Survivorship for Patients With Head and Neck Cancer

    October 18th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm

2

Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib

3

FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care

4

How the Emerging MPN Pipeline Will Reshape PV Nursing and Patient Care

5

FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us